Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

amyloid pathology in one model and tau pathology in another model, that Xenon had protective effects in both situations," said senior and co-corresponding author David M. Holtzman, MD, from ...

Now, research has identified a potential new therapy for Alzheimer’s — xenon gas. In a mouse model, researchers found that xenon gas inhalation suppressed neuroinflammation and reduced brain ...

amyloid pathology in one model and tau pathology in another model, that Xenon had protective effects in both situations," said senior and co-corresponding author David M. Holtzman, MD, from ...

VANCOUVER, British Columbia and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering ...

amyloid pathology in one model and tau pathology in another model, that Xenon had protective effects in both situations,” said senior and co-corresponding author David M. Holtzman, MD ...

amyloid pathology in one model and tau pathology in another model, that Xenon had protective effects in both situations," said senior and co-corresponding author David M. Holtzman, MD, from ...

OpenAI just released o3-mini, a reasoning model that’s faster, cheaper, and more accurate than its predecessor. On Thursday, Microsoft announced that it’s rolling OpenAI's reasoning model o1 ...

Tesla has revealed a new-look Model Y meant for the Chinese and other Asian-Pacific markets, marking the first major update to the SUV since its launch in 2020. The redesign comes as Tesla ...

The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its molecular structure, don’t typically interact with many chemicals.

Tesla's updated Model Y, code-named Juniper, has been revealed in China The updates include new styling and improved range and acceleration Deliveries start in China in March and are anticipated ...

Xenon Pharmaceuticals (XENE) outlined progress within its pipeline programs and key milestones for 2025. Phase 3 azetukalner clinical studies in focal onset seizures continue to advance, with the ...